TrialThe Lancet. Oncology2021
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Hussein A Tawbi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
187 papers cite itlatest 60 shown
this paperpooled ittrialcites it